Loading
Connectivity Analysis / Subjective Cognitive Impairment / Alzheimer Disease · Interventional Study
ClinicalTrials.gov · September 3, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registered interventional trial examining cognitive and quality-of-life outcomes over 36 months in persons with Alzheimer disease, mild cognitive impairment, or subjective cognitive impairment using multimodal assessments including neuropsychology, biomarkers, physical activity, nutrition, and digital platforms. No results are yet reported in this registry entry; the study's design characteristics and actual efficacy remain unknown.
Interventional, Single Group, Open label, Prevention purpose. Alzheimer Disease, Subjective Cognitive Impairment, Mild Cognitive Impairment; age from 50 Years; to 85 Years. Intervention: SCD/MCI. n = 200. 1 site: Italy.
This is a registered interventional trial examining cognitive and quality-of-life outcomes over 36 months in persons with Alzheimer disease, mild cognitive impairment, or subjective cognitive impairment using multimodal assessments including neuropsychology, biomarkers, physical activity, nutrition, and digital platforms. No results are yet reported in this registry entry; the study's design characteristics and actual efficacy remain unknown.
No results are reported in this registry record; outcomes, effect sizes, and safety data are unavailable.
The source did not state who this applies to in practice.
This is a clinical trial registry record describing an active, enrolling study with no results posted; it represents planned methodology only.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06896201). This is a study registration, not published results. Lead sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 200 participants (ESTIMATED). Conditions: Alzheimer Disease, Subjective Cognitive Impairment, Mild Cognitive Impairment. Interventions: DIAGNOSTIC_TEST: Neuropsychological Assessments and Other Questionnaires; BIOLOGICAL: Blood Exams, Fluid Biomarkers, Genetics; OTHER: Connectivity Analysis; DEVICE: Physical Activity; DEVICE: Healthentia; DEVICE: Eligence; OTHER: Nutrition. Primary outcome measures: Changes in cognitive performance and quality of life through cognitive scales (MiniMental State Examination) , after 36 months; Changes in cognitive performance and quality of life through cognitive scales (Clinical Dementia Rating Scale) , after 36 months; Changes in cognitive performance and quality of life through cognitive scales (Activities of the Daily Living) , after 36 months; Changes in cognitive performance and quality of life through cognitive scales (Instrumental activities of the daily living) , after 36 months; Changes in cognitive performance and quality of life through questionnaires (Quality of sleep) , after 36 months; Changes in cognitive performance and quality of life through questionnaires (Cognitive reserve) , after 36 months. Brief summary: Study is Interventional, cross-sectional, clinical trial without drug and without device
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.